Dataset Information


TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations.

ABSTRACT: TERT promoter (TERTp) mutations are found in the majority of World Health Organization (WHO) grade IV adult IDH wild-type glioblastoma (IDH-wt GBM). Here, we characterized the subset of IDH-wt GBMs that do not have TERTp mutations. In a cohort of 121 adult grade IV gliomas, we identified 109 IDH-wt GBMs, after excluding 11 IDH-mutant cases and one H3F3A -mutant case. Within the IDH-wt cases, 16 cases (14.7%) were TERTp wild-type (TERTp-wt). None of the 16 had BRAF V600E or H3F3A G34 hotspot mutations. When compared to TERTp mutants, patients with TERTp-wt GBMs, were significantly younger at first diagnosis (53.2 years vs. 60.7 years, p?=?0.0096), and were more frequently found to have cerebellar location (p?=?0.0027). Notably, 9 of 16 (56%) of TERTp-wt GBMs contained a PIK3CA or PIK3R1 mutation, while only 16/93 (17%) of TERTp-mutant GBMs harbored these alterations (p?=?0.0018). As expected, 8/16 (50%) of TERTp-wt GBMs harbored mutations in the BAF complex gene family (ATRX, SMARCA4, SMARCB1, and ARID1A), compared with only 8/93 (9%) of TERTp-mutant GBMs (p?=?0.0003). Mutations in BAF complex and PI3K pathway genes co-occurred more frequently in TERTp-wt GBMs (p?=?0.0002), an association that has been observed in other cancers, suggesting a functional interaction indicative of a distinct pathway of gliomagenesis. Overall, our finding highlights heterogeneity within WHO-defined IDH wild-type GBMs and enrichment of the TERTp-wt subset for BAF/PI3K-altered tumors, potentially comprising a distinct clinical subtype of gliomas.


PROVIDER: S-EPMC6193287 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5574236 | BioStudies
2017-01-01 | S-EPMC5596181 | BioStudies
1000-01-01 | S-EPMC4637696 | BioStudies
1000-01-01 | S-EPMC4933482 | BioStudies
2017-01-01 | S-EPMC5445205 | BioStudies
2020-01-01 | S-EPMC7586143 | BioStudies
2014-01-01 | S-EPMC4229642 | BioStudies
2019-01-01 | S-EPMC6770353 | BioStudies
2018-01-01 | S-EPMC6320119 | BioStudies
2019-01-01 | S-EPMC6422442 | BioStudies